DSCPX | FSSNX | DSCPX / FSSNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 13 years | - |
Gain YTD | 5.478 | 16.770 | 33% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.02B | 29.5B | 3% |
Annual Yield % from dividends | 0.58 | 1.36 | 43% |
Returns for 1 year | 8.60 | 19.49 | 44% |
Returns for 3 years | 3.13 | 12.65 | 25% |
Returns for 5 years | 24.44 | 46.38 | 53% |
Returns for 10 years | N/A | 90.42 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 62.33 | 0.78 | +1.27% |
Virtus LifeSci Biotech Products ETF | |||
PWV | 57.84 | -0.24 | -0.41% |
Invesco Large Cap Value ETF | |||
AVUV | 100.03 | -1.42 | -1.40% |
Avantis US Small Cap Value ETF | |||
TSME | 38.33 | -0.58 | -1.49% |
Thrivent Small-Mid Cap ESG ETF | |||
AMUB | 18.50 | -0.56 | -2.96% |
UBS ETRACS Alerian MLP ETN Series B |